| Treatment of Homonymous Visual Field Defects. | |
| | |
MedLine Citation:
|
PMID: 22203236 Owner: NLM Status: Publisher |
Abstract/OtherAbstract:
|
OPINION STATEMENT: A clinical presentation of a retrochiasmal or homonymous visual field defect (HVFD) usually represents a permanent visual impairment. The visual and functional ramifications of HVFD will vary by patient. Comprehensive care-the clinical evaluation and consideration for treatment of HVFD-includes vision rehabilitation provided by optometrists, occupational therapists, or ophthalmologists. On the basis of individual patient needs, the eye care practitioner typically uses one or both of the following approaches to treat the HVFD: (1) field enhancement (also referred to in the literature as "field expansion"), in which optical systems incorporating prism are prescribed to optimize the use of the remaining vision, and (2) rehabilitative techniques including saccadic training ("compensation training") or vision restorative therapy ("restitution training"). Although lacking in strength, the evidence does support benefits from field enhancement and saccadic training for patients with HVFD, but vision restorative therapy has not been shown to be an effective option. |
| | |
Authors:
|
Daniel R Gold; Lori L Grover |
Related Documents
:
|
16404456 - Competing perspectives during organizational socialization on the role of certified ath... 9209816 - The athletic trainer's perspective. 14652496 - Training-specific muscle architecture adaptation after 5-wk training in athletes. 3881196 - The administration of gymnastics in the united states. 1056286 - Evaluating attitude change in community dental service programs in minnesota, u.s.a. 8136066 - Intact acquisition and long-term retention of mirror-tracing skill in alzheimer's disea... |
Publication Detail:
|
Type: JOURNAL ARTICLE Date: 2011-12-29 |
Journal Detail:
|
Title: Current treatment options in neurology Volume: - ISSN: 1534-3138 ISO Abbreviation: - Publication Date: 2011 Dec |
Date Detail:
|
Created Date: 2011-12-28 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 9815940 Medline TA: Curr Treat Options Neurol Country: - |
Other Details:
|
Languages: ENG Pagination: - Citation Subset: - |
Affiliation:
|
Department of Neurology, University of Maryland Medical Center, 110 S. Paca St., 3rd Floor, Baltimore, MD, 21201, USA, dgold004@umaryland.edu. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Chlamydia pneumoniae entry into epithelial cells by clathrin-independent endocytosis.
Next Document: Bevacizumab for glioblastoma refractory to vascular endothelial growth factor receptor inhibitors.